Early access to medicines in Europe: Compassionate use to become a reality

EURORDIS has published a position arguing for compassionate use programmes for medicines to be made more widely available to those patients in need of urgent help.

At the moment the length of time needed to fully develop a medicine is too long for some patients. A compassionate use programme which takes places before the authorisation process has been carried out can offer a hope of treatment to those patients who are willing to take a higher risk with a non-tested product. Allowing early access to these promising new treatments, before their efficacy and safety have been fully established, can save lives.

At the moment not all countries benefit from a compassionate use programme, and different patients can access them at different times depending on where they live. EURORDIS proposes different policy ideas to help counteract this and offers recommendations to patients’ organisations, industry, member states and European authorities.

The Paper also takes ethical principles into consideration: namely the need for equal access for all patients to the treatment; transparency of the programme for the patients and general public; and a clear definition of who will benefit from the programme.

Please find the annexes for the Position Paper here.

 

 
 
The voice of rare disease patients in EuropeEURORDIS The international voice of people living with rare diseases, Rare Diseases International is a EURORDIS initiativeRare Disease International Bringing together patients, families and experts to share experiences in a moderated multilanguage forum, RareConnect is a EURORDIS initiative RareConnect An international awareness raising campaign taking place on the last day of February each year, Rare Disease Day is a EURORDIS initiativeRare Disease Day Join the largest gathering of rare disease stakeholders across Europe, at the biennial European Conference on Rare Diseases and Orphan Products. ECRD is a EURORDIS initiativeEuropean Conference on Rare Diseases